BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35574284)

  • 1.
    Almalki S; Beigh S; Akhter N; Alharbi RA
    Saudi J Biol Sci; 2022 Jun; 29(6):103283. PubMed ID: 35574284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Designing a multi-epitope vaccine to provoke the robust immune response against influenza A H7N9.
    Tarrahimofrad H; Rahimnahal S; Zamani J; Jahangirian E; Aminzadeh S
    Sci Rep; 2021 Dec; 11(1):24485. PubMed ID: 34966175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine.
    De Groot AS; Ardito M; McClaine EM; Moise L; Martin WD
    Vaccine; 2009 Sep; 27(42):5740-7. PubMed ID: 19660593
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In silico design of recombinant multi-epitope vaccine against influenza A virus.
    Maleki A; Russo G; Parasiliti Palumbo GA; Pappalardo F
    BMC Bioinformatics; 2022 Feb; 22(Suppl 14):617. PubMed ID: 35109785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A computational approach to design a multiepitope vaccine against H5N1 virus.
    Dashti F; Raisi A; Pourali G; Razavi ZS; Ravaei F; Sadri Nahand J; Kourkinejad-Gharaei F; Mirazimi SMA; Zamani J; Tarrahimofrad H; Hashemian SMR; Mirzaei H
    Virol J; 2024 Mar; 21(1):67. PubMed ID: 38509569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus.
    Moin AT; Patil RB; Tabassum T; Araf Y; Ullah MA; Snigdha HJ; Alam T; Alvey SA; Rudra B; Mina SA; Akter Y; Zhai J; Zheng C
    Microbiol Spectr; 2022 Oct; 10(5):e0115122. PubMed ID: 36094198
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conservation and diversity of influenza A H1N1 HLA-restricted T cell epitope candidates for epitope-based vaccines.
    Tan PT; Heiny AT; Miotto O; Salmon J; Marques ET; Lemonnier F; August JT
    PLoS One; 2010 Jan; 5(1):e8754. PubMed ID: 20090904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling mRNA-based vaccine YFV.E1988 against yellow fever virus E-protein using immuno-informatics and reverse vaccinology approach.
    Khan NT; Zinnia MA; Islam ABMMK
    J Biomol Struct Dyn; 2023 Mar; 41(5):1617-1638. PubMed ID: 34994279
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Jalalvand A; Fotouhi F; Bahramali G; Bambai B; Farahmand B
    J Biomol Struct Dyn; 2023 Dec; ():1-17. PubMed ID: 38088331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine Design for H5N1 Based on B- and T-cell Epitope Predictions.
    Tambunan US; Sipahutar FR; Parikesit AA; Kerami D
    Bioinform Biol Insights; 2016; 10():27-35. PubMed ID: 27147821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoinformatic paradigm predicts macrophage and T-cells epitope responses against globally conserved spike fragments of SARS CoV-2 for universal vaccination.
    Maiti S; Banerjee A; Santra D; Kanwar M
    Int Immunopharmacol; 2022 Jul; 108():108847. PubMed ID: 35597120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole proteome screening and identification of potential epitopes of SARS-CoV-2 for vaccine design-an immunoinformatic, molecular docking and molecular dynamics simulation accelerated robust strategy.
    Ezaj MMA; Junaid M; Akter Y; Nahrin A; Siddika A; Afrose SS; Nayeem SMA; Haque MS; Moni MA; Hosen SMZ
    J Biomol Struct Dyn; 2022 Sep; 40(14):6477-6502. PubMed ID: 33586620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of epitope-based vaccine design against the novel SARS-CoV-2.
    Chen HZ; Tang LL; Yu XL; Zhou J; Chang YF; Wu X
    Infect Dis Poverty; 2020 Jul; 9(1):88. PubMed ID: 32741372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus.
    Singh J; Malik D; Raina A
    Vaccine; 2021 Feb; 39(7):1087-1095. PubMed ID: 33478787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conservation region finding for influenza A viruses by machine learning methods of N-linked glycosylation sites and B-cell epitopes.
    Liu JH; Chang CC; Chen CW; Wong LT; Chu YW
    Math Biosci; 2019 Sep; 315():108217. PubMed ID: 31220511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In-depth phylodynamics, evolutionary analysis and in silico predictions of universal epitopes of Influenza A subtypes and Influenza B viruses.
    DurĂ£es-Carvalho R; Salemi M
    Mol Phylogenet Evol; 2018 Apr; 121():174-182. PubMed ID: 29355604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Universal Influenza Virus Neuraminidase Vaccine Elicits Protective Immune Responses against Human Seasonal and Pre-pandemic Strains.
    Skarlupka AL; Bebin-Blackwell AG; Sumner SF; Ross TM
    J Virol; 2021 Aug; 95(17):e0075921. PubMed ID: 34160258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel in silico minigene vaccine based on CD4
    Pourseif MM; Moghaddam G; Naghili B; Saeedi N; Parvizpour S; Nematollahi A; Omidi Y
    Comput Biol Chem; 2018 Feb; 72():150-163. PubMed ID: 29195784
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Jahantigh HR; Stufano A; Lovreglio P; Rezaee SA; Ahmadi K
    J Biomol Struct Dyn; 2022 Sep; 40(15):6737-6754. PubMed ID: 33648421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.